Microvision, Inc. (MVIS) Rating Increased to Buy at Zacks Investment Research

Zacks Investment Research upgraded shares of Microvision, Inc. (NASDAQ:MVIS) from a hold rating to a buy rating in a research note released on Tuesday. They currently have $3.00 target price on the electronics maker’s stock.

According to Zacks, “Microvision, Inc. develops information display and related technologies that allow electronically generated images and information to be projected onto a viewer’s eye. They defined three distinct business platforms relating to the delivery of images and information in this manner: Retinal Scanning Displays, Imaging Solutions, Optical Material technology. “

A number of other equities analysts have also recently issued reports on MVIS. ValuEngine raised shares of Microvision from a sell rating to a hold rating in a report on Friday, June 30th. HC Wainwright set a $4.00 target price on shares of Microvision and gave the stock a buy rating in a report on Friday, August 4th. Finally, Northland Securities set a $3.00 target price on shares of Microvision and gave the stock a buy rating in a report on Friday, August 4th. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. The company presently has an average rating of Buy and an average target price of $3.50.

Microvision (NASDAQ MVIS) opened at 2.47 on Tuesday. The company has a 50-day moving average price of $2.64 and a 200 day moving average price of $2.31. Microvision has a 12 month low of $0.89 and a 12 month high of $3.25. The firm’s market cap is $176.84 million.

Microvision (NASDAQ:MVIS) last issued its earnings results on Thursday, August 3rd. The electronics maker reported ($0.08) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.10) by $0.02. Microvision had a negative net margin of 224.93% and a negative return on equity of 677.56%. The firm had revenue of $1.50 million for the quarter, compared to analysts’ expectations of $0.74 million. During the same quarter last year, the company posted ($0.07) earnings per share. Microvision’s revenue was down 64.3% on a year-over-year basis. Equities research analysts anticipate that Microvision will post ($0.29) EPS for the current year.

WARNING: This piece of content was originally reported by BBNS and is the sole property of of BBNS. If you are reading this piece of content on another site, it was illegally stolen and republished in violation of US and international copyright legislation. The correct version of this piece of content can be read at https://baseballnewssource.com/markets/microvision-inc-mvis-rating-increased-to-buy-at-zacks-investment-research/1705522.html.

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Bank of New York Mellon Corp raised its holdings in shares of Microvision by 13.7% during the first quarter. Bank of New York Mellon Corp now owns 43,935 shares of the electronics maker’s stock valued at $109,000 after buying an additional 5,283 shares during the last quarter. Voya Investment Management LLC bought a new stake in shares of Microvision during the second quarter valued at approximately $101,000. Rhumbline Advisers bought a new stake in shares of Microvision during the second quarter valued at approximately $139,000. Schwab Charles Investment Management Inc. bought a new stake in shares of Microvision during the second quarter valued at approximately $250,000. Finally, Teachers Advisors LLC bought a new stake in shares of Microvision during the second quarter valued at approximately $256,000. 27.12% of the stock is currently owned by institutional investors.

Microvision Company Profile

Microvision, Inc is a developer of laser beam scanning (LBS) technology. The Company markets its technology under the brand name, PicoP. It has developed PicoP scanning technology that can be adopted by its customers to create high-resolution miniature projection, and three-dimensional sensing and image capture solutions that use laser diodes as the light source.

Get a free copy of the Zacks research report on Microvision (MVIS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Microvision Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microvision Inc. and related companies with our FREE daily email newsletter.

 


Latest News

Houston’s Dallas Keuchel Could Make Relief Appearance in Game 7
Houston’s Dallas Keuchel Could Make Relief Appearance in Game 7
Houston Astros Relying on Justin Verlander to Save Their Season
Houston Astros Relying on Justin Verlander to Save Their Season
Clayton Kershaw Gets Chance to Pitch LA into Fall Classic
Clayton Kershaw Gets Chance to Pitch LA into Fall Classic
Aaron Judge and Gary Sanchez Have Break Out Games
Aaron Judge and Gary Sanchez Have Break Out Games
Justin Turner Joining Postseason Legends
Justin Turner Joining Postseason Legends
PED Use Cost Alex Rodriguez Millions and His Reputation
PED Use Cost Alex Rodriguez Millions and His Reputation


Leave a Reply

 
© 2006-2017 BBNS.